Dr. Link is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
230 S. Main St
Suite 100
Orange, CA 92868Phone+1 714-541-0101Fax+1 714-541-0450
Education & Training
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 1972 - 1974
Keck School of Medicine of the University of Southern CaliforniaClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Top MD Consumers Checkbook
Clinical Trials
- Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy Start of enrollment: 2008 Nov 10
- NBRST: Prospective Neo-adjuvant REGISTRY Trial Start of enrollment: 2011 Jul 01
- Open-label, Phase II, Study of Everolimus Plus Letrozole in Postmenopausal Women With ER+, HER2- Metastatic or Locally Advanced Breast Cancer Start of enrollment: 2013 Mar 07
Publications & Presentations
PubMed
- 31 citationsProject Connect Online: Randomized Trial of an Internet-Based Program to Chronicle the Cancer Experience and Facilitate CommunicationAnnette L. Stanton, Elizabeth H. Thompson, Catherine M. Crespi, John S. Link, James Waisman
Journal of Clinical Oncology. 2013-09-20 - 212 citationsConcurrent Trastuzumab and HER2/neu-Specific Vaccination in Patients With Metastatic Breast CancerMary L. Disis, Danelle R. Wallace, Ted Gooley, Yushe Dang, Meredith Slota
Journal of Clinical Oncology. 2009-10-01 - 375 citationsNeratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3...Miguel Martin, Frankie A. Holmes, Bent Ejlertsen, Suzette Delaloge, Beverly Moy
The Lancet. Oncology. 2017-12-01
Press Mentions
Dr. John Link to Speak at Cancer Support Community PasadenaJanuary 8th, 2018
These SCNG Columnists Are Cancer Stars. Here’s How to Hear Their StoriesJune 4th, 2023- 2 SCNG Columnists Among Those Honored at Long Beach Cancer League GalaJune 5th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
